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Abstract  20 
Alternative treatments to surgery in canine degenerative lumbosacral stenosis 21 
(DLSS) remain limited and reliable predictors of outcome are lacking. The aims of this 22 
clinical trial were threefold: to assess the usefulness of single epidural steroid injection 23 
(ESI) in DLSS, to compare the outcomes of ESI and decompressive surgery, and 24 
evaluate ESI as a predictor of outcome following decompressive surgery. 25 
Dogs diagnosed with DLSS were prospectively recruited and administered an 26 
ESI. If clinical signs persisted or relapsed, decompressive surgery was recommended. 27 
Follow-up was obtained. Thirty-two dogs underwent ESI with 17 having subsequent 28 
surgery. Improvement after ESI was seen in 27/32 dogs (84.4%), with 17/22 (77.2%) 29 
relapsing within six months (15/17 relapsing within two months). Five dogs failed to 30 
respond to ESI and another five (15.6%) presented a persistent post-ESI favourable 31 
response (mean follow-up time, 9.4 months). Post-surgical improvement occurred in all 32 
dogs. Outcome appeared more favourable following surgical decompression, with a 33 
trend towards reduced pain, increased mobility, and greater quality of life score.  34 
This study was unable to demonstrate that ESI could predict surgical outcome. 35 
ESI was confirmed as an effective treatment in most but not all cases, leading to 36 
transient alleviation of clinical signs for longer than previously reported. ESI provided a 37 
complete and apparently long-term sustained resolution of clinical signs in a subset of 38 
dogs. Despite this, there was indication that surgical decompression can lead to a more 39 
favourable outcome. Epidural steroid injection has a role in the management of DLSS 40 
dogs, particularly when surgery is not an option. 41 
 42 
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 3 
Introduction 44 
Degenerative Lumbosacral Stenosis (DLSS) is an acquired multifactorial 45 
condition, involving alterations of the tissues surrounding the cauda equina and nerve 46 
roots, where progressive stenosis of the vertebral canal and/or the intervertebral 47 
foramina gives rise to neurological dysfunction and pain in dogs (De Risio et al., 2001; 48 
Gödde and Steffen, 2007; Jeffery et al., 2014; Gomes et al., 2018). Several treatment 49 
strategies have been described in addressing DLSS with variable success. Reports 50 
describing conservative management alone revealed improvement in the clinical signs 51 
in about 50% of dogs, being based on the adoption of non-standardised protocols, with 52 
different medications and restricted exercise (Denny et al., 1982; Ness, 1994; De 53 
Decker et al., 2014). Surgical management of DLSS has been more extensively reported 54 
with clinical improvement identified in 67% to 97% of cases (Danielsson and Sjöström, 55 
1999; Janssens et al., 2000; Jones et al. 2000; De Risio et al., 2001; Linn et al., 2003; 56 
Gödde and Steffen, 2007; Suwankong et al., 2008; Hankin et al., 2012; Smolders et al., 57 
2012; Golini et al., 2014; Gomes et al., 2018). 58 
An alternative method has been described in a single retrospective study, 59 
through the infiltration of methylprednisolone acetate in the epidural space over the L7-60 
S1 intervertebral disc in a population of 38 dogs (Janssens et al., 2009). Although this 61 
has not yet been established in veterinary medicine, the terminology “epidural steroid 62 
injection” (ESI) is used in human medicine to describe this procedure (Buttermann, 63 
2004; McLain et al., 2005; Wilkinson and Cohen, 2013) and seems an appropriate term 64 
for veterinary patients. We define this term as the translaminar instillation of 65 
methylprednisolone acetate into the epidural region over the L7-S1 intervertebral disc as 66 
described by Janssen and others (Janssen et al., 2009).  67 
In that same report (Janssen et al., 2009), all dogs were reported to improve 68 
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following the first ESI with 18.4% receiving a single-instillation, and long-term clinical 69 
improvement reported in 79% of dogs following more than one ESI. Specific details on 70 
outcome of the subpopulation receiving a single-instillation are not described or are 71 
difficult to infer, and it is questionable if a single ESI can be applied successfully as 72 
treatment in DLSS affected dogs. The study also demonstrated that ESI had a temporary 73 
effect, requiring several repeated procedures to achieve a more prolonged effect 74 
(Janssens et al., 2009). The same study based DLSS diagnosis on epidurography or 75 
discography with no advanced imaging being performed. No further articles have 76 
investigated ESI efficacy in canine DLSS. 77 
Epidural steroid injection is generally considered a safe procedure in dogs (Janssens et 78 
al., 2009; Liotta et al., 2016; Salmelin et al., 2019). The theoretical advantages of ESI 79 
over oral medication include a more targeted therapy, being applied in the immediate 80 
vicinity of the affected nerve roots, potentially leading to less systemic effects and 81 
higher local dosages (McLain et al., 2005). These advantages, allied with a rapid 82 
response to treatment, gives ESI the potential of being used as a single treatment, a 83 
diagnostic test or even as predictor of subsequent outcome following surgical 84 
management of DLSS. Several prognostic factors for post-surgical failure in DLSS have 85 
been reported including the presence of faecal or urinary incontinence, urinary 86 
incontinence of more than one month in duration (De Risio et al., 2001; Linn et al., 87 
2003), increased age of onset of clinical signs, radiographic presence of foraminal 88 
narrowing, presence of paresis, proprioceptive deficits, pelvic limb muscle atrophy and 89 
the identification of hypertrophic articular facets and the interarcuate ligament 90 
intraoperatively (Linn et al., 2003). However, no diagnostic test has been identified 91 
predicting post-surgical outcome in DLSS. Epidural steroid injection appears to be a 92 
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good candidate for this purpose due to its rapid relief of clinical signs when effective, 93 
and the ability to perform the procedure at the time of advanced imaging diagnosis. 94 
The aims of this clinical trial were threefold; to assess the usefulness of single 95 
instillation ESI in the treatment of DLSS, to compare the outcomes of ESI and 96 
decompressive surgery, and to evaluate the clinical response of ESI as a predictor of 97 
outcome for subsequent decompressive surgery. We hypothesise that a successful but 98 
transient response to ESI could be an indicator of a successful outcome of subsequent 99 
surgical decompression. 100 
 101 
Material and Methods 102 
Study design 103 
This prospective study was based on previously validated treatment options for 104 
DLSS affected dogs (Gödde and Steffen, 2007; Janssens et al., 2009; Gomes et al., 105 
2018). Ethical approval for the study was granted by The School of Veterinary 106 
Medicine and Science at the University of Nottingham (Approval number: 2711 107 
190326; Approval date: 10 May 2019). Written informed consent was obtained from 108 
owners of all dogs prior to enrollment. 109 
Dogs presented to the neurology service at a single referral hospital between 110 
February 2017 and May 2019, with clinical signs compatible with DLSS were 111 
consecutively prospectively recruited. 112 
Inclusion criteria were (1) clinical confirmation of DLSS through compatible 113 
clinical signs, (2) magnetic resonance imaging (MRI) evidence of intervertebral 114 
foraminal stenosis with identification of L7 nerve root enlargement and/or lumbosacral 115 
vertebral canal stenosis (Gödde and Steffen, 2007; Gomes et al., 2018). Evidence of 116 
foraminal stenosis was based on one or more of the criteria: (1) complete loss of fat 117 
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signal or only a minimal rim of fat signal left in the foraminal zone in parasagittal or 118 
transverse T2W images; (2) presence of a compressive asymmetric intervertebral disc 119 
protrusion on transverse T2W images at the level of the intervertebral foramina; (3) the 120 
presence of an ipsilateral hyperintense L7 nerve root on transverse T2W images and 121 
dorsal STIR. Evidence of vertebral canal stenosis was based on the presence of over 25 122 
per cent of lumbosacral vertebral canal attenuation on midsagittal images, including 123 
compression secondary to L7-S1 intervertebral disc protrusion (Gödde and Steffen, 124 
2007; Gomes et al., 2018). 125 
Dogs presenting with concomitant relevant orthopaedic, neoplastic, 126 
inflammatory, developmental conditions or evidence of L7-S1 intervertebral disc 127 
extrusion were excluded. Concomitant orthopaedic conditions were specifically 128 
excluded based on a normal orthopaedic examination and no evidence of an overt 129 
orthopaedic condition on pelvic limb radiography or computed tomography when 130 
available for review. 131 
Owners of dogs that potentially met the inclusion criteria were informed of the 132 
clinical trial at time of admission, and offered an initial ESI at time of diagnosis. 133 
Decompressive surgery was offered to the veterinary patients when ESI was 134 
unsuccessful or following relapse of clinical signs. Procedures and time frames are 135 
detailed below.  136 
Owner questionnaires were devised enquiring about the presence of typical 137 
clinical features of DLSS. Inferred pain, mobility and quality of life were assessed 138 
through three numerical 0 to 10 whole number scales: when referring to inferred pain, 0 139 
corresponded to no pain and 10 to extreme pain; when referring to mobility and quality 140 
of life, 0 meant poor and 10 meant good mobility or quality of life. Three questionnaires 141 
were devised and provided to the owners at three different time-points: at initial 142 
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consultation (Supplement 1), two to four weeks following ESI (Supplement 2), and six 143 
to eight weeks following surgical management (Supplement 3).  144 
Signalment, weight, duration of clinical signs, previous treatments attempted, 145 
clinical and neurological findings were recorded. Dogs were initially classified into 146 
clinical severity groups through the use of a mild, moderate and severe grading scoring 147 
system (Gomes et al., 2018). Mild cases presented DLSS compatible clinical signs (e.g. 148 
lumbosacral pain, reluctance to climb stairs/jump/raise up, lameness, muscle atrophy) 149 
but no neurological deficits. Moderate cases presented DLSS compatible clinical signs 150 
plus neurological deficits considered moderate (reduced flexor withdrawal, 151 
proprioceptive deficits, nerve root signature/toe touching). Severe cases presented 152 
DLSS compatible clinical signs plus neurological deficits considered more severe (tail 153 
paresis, absent perineal reflex). Dogs were classified as pet dogs or working dogs, the 154 
latter category including agility dogs. Daily exercise length was classified as above or 155 
below an hour. 156 
 157 
Diagnosis and epidural steroid injection 158 
Following clinical and MRI diagnosis of DLSS, each dog underwent an ESI 159 
under general anaesthesia. General anaesthesia protocol was standardised for all dogs. 160 
Instillation of methylprednisolone acetate (Depo-Medrone 40 mg/ml, Pfizer) was 161 
performed into the lumbosacral epidural space in accordance with a previously reported 162 
dosage protocol, of 1 mg/kg with a minimal volume of 0.5 ml (Janssens et al., 2009). In 163 
order to confirm the correct placement of the needle, a neurostimulation technique was 164 
performed following a previously validated method, with the animal in sternal decubitus 165 
(Garcia-Pereira et al., 2010). A disposable spinal needle electrode (Natus TECA 166 
MyoJect, 50 mm length, 25 gauge) was placed and muscle twitching of the tail at a 167 
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stimulus intensity up to 0.30 mA was required before local instillation (Garcia-Pereira et 168 
al., 2010). Epidural steroid injections were performed by the authors. Following ESI, all 169 
dogs were discharged with instructions for restricted exercise and continuation of their 170 
current oral treatment protocol in order to avoid interference with ESI, except when 171 
managed with non-steroidal anti-inflammatory drugs which were stopped. Restricted 172 
exercise instructions were that owners should only take the dogs on short-walks on a 173 
lead, and that strenuous activity (e.g. agility) should be avoided until a response to 174 
treatment was identifiable. 175 
The owners were handed the first questionnaire at initial consultation 176 
(Supplement 1). A follow-up consultation was performed between two to four weeks 177 
later, in accordance with previously reported median length of ESI effect of 11 days 178 
(range, 4–14 days) (Janssens et al., 2009). A second questionnaire was handed to the 179 
owners at that time (Supplement 2). Information was obtained from owners regarding 180 
complications, particularly focusing on signs of systemic absorption of corticosteroids 181 
such as polyphagia, polydipsia and polydipsia (Behrend and Kemppainen, 1997; 182 
Salmelin et al., 2019). The length of time until clinical response was observed through 183 
an open question in the second questionnaire. 184 
 185 
Surgical decompression 186 
Surgical decompression was offered to veterinary patients following a minimum 187 
period of two weeks following ESI, when unsuccessful or after relapse of clinical signs. 188 
Lateral foraminotomy (unilateral or bilateral) was performed when there was evidence 189 
of foraminal stenosis at the level of the lumbosacral junction, with a concurrent dorsal 190 
laminectomy when there was evidence of midline vertebral canal stenosis (Gödde and 191 
Steffen, 2007; Gomes et al., 2018). Concurrent L7-S1 discectomy was not performed 192 
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(Gomes et al., 2018). Surgical procedures were performed by two board-certified 193 
neurologists. Following surgery, dogs were discharged with instructions of cage rest for 194 
four to six weeks, rehabilitation under guidance of a qualified animal physiotherapist 195 
and concurrent pain-relief as required (e.g. non-steroidal anti-inflammatory medication 196 
and/or gabapentin). Dogs would then be allowed to gradually resume regular exercise 197 
and routine. Follow-up consultations were performed between six to eight weeks 198 
following surgery and a third questionnaire was given to the owners (Supplement 2). 199 
 200 
Outcome 201 
Outcome was divided into (1) clinical outcome, as assessed by a board certified 202 
neurologist on follow-up consultations, (2) owner inferred outcome based on pain, 203 
mobility and quality of life scores obtained through questionnaires. 204 
Clinical outcome to both ESI and surgical decompression was considered (1) 205 
complete if clinical signs had resolved at follow-up consultations (2) partial if there was 206 
substantial but incomplete improvement in clinical signs (3) failed if the dog did not 207 
improve or deteriorated further. Relapse was assessed following initial response to ESI 208 
or surgical decompression, being defined as deterioration of clinical signs following an 209 
initial improvement. Time from ESI to relapse was obtained at the time of completion 210 
of the second questionnaire or, if occurring later, through telephone interviews with the 211 
owners. Follow-up time was collected for dogs without relapse through telephone 212 
interviews with the owners at the time of completion of this study. 213 
In dogs undergoing both ESI and surgical decompression, comparison of clinical 214 
and owner inferred outcome was performed. 215 
 216 
Results 217 
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A total of 88 dogs were consecutively assessed for enrolment for a suspected 218 
diagnosis of DLSS. Thirty-eight dogs were excluded for presenting a non-DLSS 219 
diagnosis, details are described in Fig. 1. Of the remaining 50 dogs, 41 dogs underwent 220 
ESI with nine dogs receiving an alternative treatment modality at the owner’s request. 221 
Following ESI, nine dogs did not return for a follow-up consult failing to complete the 222 
second questionnaire. Thirty-two dogs were re-examined and completed the 223 
questionnaire following ESI. All dogs had undergone unsuccessful medical 224 
management through non-standardised medication protocols and restricted exercise 225 
before presentation. 226 
 227 
Animals 228 
Breed distribution was Labrador Retriever (n = 6), Border Collie (4), Crossbreed 229 
(4), German Shepherd Dog (3), Golden Retriever (2), Airedale Terrier, Beagle, Belgian 230 
Shepherd Dog, Boxer, Chinese Shar-pei, Cocker Spaniel, Dalmatian, German Pointer, 231 
Rhodesian Ridgeback, Rottweiler, Siberian Husky, Springer Spaniel, Staffordshire Bull 232 
Terrier (1 for each). Seventeen males and 15 females were identified with a mean age of 233 
75.1 months (median, 70.5; range, 15-150). Mean duration of clinical signs before 234 
diagnosis was of 4.7 months (median, 4; range, 0.25-12) and mean weight was of 27.4 235 
kg (median, 27.1; range, 6.8-42.6). A total of five dogs were working or agility dogs 236 
(15.6%), with 17 (53.1%) being exercised for over 1 hour daily. 237 
 238 
Outcome 239 
Clinical outcome is detailed in Table 1. Thirty-two dogs were assessed 240 
following ESI. Initial grading score was mild in 14 (43.8%), moderate in 15 (46.9%) 241 
and severe in three (9.4%) dogs. 242 
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An improvement after ESI was seen in 27/32 dogs (84.4%) with partial response 243 
in 14 dogs and a complete response in 13 dogs. In five dogs (15.6%) no clinical 244 
response to ESI was evident. All five dogs where no clinical response was identifiable 245 
had subsequent surgical decompression. Of the 14 dogs in which a partial response was 246 
seen, nine relapsed with seven having surgical decompression, one opting to have ESI 247 
repeated and one being refused further treatment by their owners; the remaining five 248 
were lost to long term follow-up. Of the 13 dogs with a complete response to ESI, eight 249 
relapsed with five subsequently having surgical decompression and three being refused 250 
further treatment by their owners; the remaining five had persistent improvement 251 
without relapse. Information on relapse post-ESI was available in 22 dogs and occurred 252 
in 17 (77.2%), at a mean of 2.4 months (median, 2; range, 0.5-6). The five dogs with a 253 
persistent improvement without relapse following ESI had a last-contact mean follow-254 
up time of 9.4 months (median, 8; range, 2-21). 255 
Time length until clinical response following ESI was only detailed by the 256 
owners of 17 dogs and was a mean of 12.9 days (median, 14; range, 2-28). No 257 
complications were identified from ESI and a single dog presented transient clinical 258 
signs compatible with systemic absorption of corticosteroids.  259 
A total of 17 dogs underwent decompressive surgery (Fig. 1). Initial grading 260 
score was mild in six, and moderate in 11 dogs. Bilateral lateral foraminotomy was 261 
performed as a standalone procedure in four dogs and with concurrent dorsal 262 
laminectomy in 13 dogs. Post-surgical improvement was identified in all 17 dogs, with 263 
a complete response seen in eight dogs and a partial response in nine dogs. No 264 
intraoperative complications were identified. In the five dogs where ESI failed to show 265 
improvement, all five improved post-surgically with partial response in two dogs and a 266 
complete response in three dogs (Table 1). 267 
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The results of owner inferred outcome are described in table 2 and depicted in 268 
Fig. 2 and Fig. 3 In the whole population receiving an ESI, there was a trend towards 269 
reduced pain, increased mobility, and greater quality of life score (Fig. 2). This same 270 
trend was identified following surgical decompression, particularly in term of pain 271 
scores (Fig. 3). An extreme post-surgical outlier of the quality of life marker (0 mark) 272 
was that of a five-year-old beagle which underwent bilateral foraminotomy combined 273 
with dorsal laminectomy (dog 15). This beagle achieved increased mobility and reduced 274 
pain, however, was assessed by the owner as having a significant reduction in quality of 275 
life due to the development of urinary and faecal incontinence following surgery. 276 
 277 
Discussion 278 
This is the first study that prospectively assesses treatment of a dog population 279 
clinically affected by DLSS (Jeffery el al., 2014). This study evaluated the value of a 280 
single instillation ESI as treatment in DLSS, comparing outcome between both ESI and 281 
surgical decompression as well as its potential value as a predictor of surgical outcome.  282 
The results of this clinical trial were in accordance with previous studies, 283 
confirming the safety and efficacy of ESI (Janssens el al., 2009; Liotta et al., 2016; 284 
Salmelin et al., 2019). Contrary to the results reported by Janssens and others (Janssens 285 
et al., 2009), 15.6% failed to demonstrate a clinical response in our study. We measured 286 
both the duration of the clinical effect of ESI (termed here as relapse), and the length of 287 
time it took for ESI to be effective according to owners. A clinical response to ESI took 288 
a mean of 12.9 days, with some dogs taking up to 28 days for a response to be 289 
noticeable. Relapse occurred within six months of ESI with a median of two months, 290 
longer than the previously reported median of 11 days (Janssens et al., 2009). This is 291 
compatible with reports in people suffering from low-back pain, where as many as 50% 292 
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of patients will be pain-free for two weeks, with only a very limited number of cases 293 
being pain-free after six months (White et al., 1980, Parr et al., 2009). Both values 294 
reveal a variable response of individuals to ESI, with ESI sometimes taking longer to 295 
act or having a longer effect than previously reported in dogs (Janssens et al., 2009).  296 
Interestingly, a subset of our population (15.6%) had a sustained, complete 297 
response to a single ESI, without relapse, with a mean follow-up time of 9.4 months. 298 
This demonstrates that a subset of DLSS affected dogs can respond to a single-299 
instillation of ESI for a longer period of time than previously reported. Further 300 
prospective studies with more dogs and a longer follow-up time would be required in 301 
order to confirm if clinical signs do eventually relapse and to help identify factors 302 
associated with such a protracted response. 303 
In humans, despite the frequent utilisation of ESI for treatment of lumbar 304 
radiculopathy, its efficacy and indications are still matter of debate (Parr et al., 2009; 305 
Roberts et al., 2009; Cohen et al., 2013). Instillation of steroids, when utilised as a 306 
single treatment, has been shown to be equivalent to a single instillation of bupivacaine 307 
or saline (Roberts et al., 2009). In dogs, only the effect of methylprednisolone delivered 308 
into the epidural space in dogs with DLSS has been assessed originally (Janssens et al., 309 
2009) and in this clinical trial. In humans despite reports of usage of 310 
methylprednisolone, hydrocortisone and triamcinolone, results are conflicting in terms 311 
of relative benefit (McLain et al., 2005). Evaluation of a placebo or lidocaine 312 
administered into the epidural space would be of great interest in dogs with DLSS given 313 
the findings in people. 314 
The mechanism of action of ESI is still not well understood and it is most likely 315 
multifactorial. Corticosteroids are commonly utilised in neurological conditions in dogs, 316 
mainly due to its anti-inflammatory or immunosuppressive effects (Platt et al., 2005). 317 
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Corticosteroids can directly or indirectly inhibit the synthesis or release of pro-318 
inflammatory mediators, alter neuromuscular junction and neuronal conductivity 319 
(namely nociceptive C-fibre conduction), and reduce oedema formation secondary to 320 
increased capillary damage and permeability (McLain et al., 2005). It is also possible 321 
that corticosteroids act in other unknown distinct mechanisms, considering its potential 322 
and sometimes deleterious effects on neural development and regeneration (Chari, 323 
2014). The direct instillation of an aqueous substance into the epidural space could lead 324 
to osmotic dilution and removal of inflammatory mediators (Wilkinson and Cohen, 325 
2013). There is also the advantage over oral medication of a more targeted 326 
corticosteroid delivery with a reduction of systemic effects (McLain et al., 2005). 327 
Epidural steroid injection is considered a relatively safe procedure in both dogs and 328 
humans (Janssens et al., 2009; Parr et al., 2009; Karaman 2011; Liotta et al., 2016; 329 
Salmelin et al., 2019), although severe complications secondary to an epidural injection 330 
have been reported in a dog (Remedios et al., 1996). ESI is a less-invasive and more 331 
affordable procedure than surgery. However, the need for repeated instillations can lead 332 
to cumulative costs and reduce owner compliance (Janssens et al., 2009). It also must be 333 
noted, that despite the delivery of a potent anti-inflammatory drug such as 334 
methylprednisolone over the affected region, inflammation appears to be a rare finding 335 
in cases of foraminal stenosis and secondary nerve root enlargement (Matiasek et al., 336 
2008). 337 
Comparison of clinical outcome in the 17 dogs undergoing both ESI and 338 
subsequent surgical decompression, revealed that a complete response was obtained in 339 
53% of cases (9/17) following surgery, against only 17.6% (3/17) following initial ESI 340 
(Table 1).  Clinical improvement was attained following surgery in all cases, despite 341 
29.4% (5/17) having previously failed to respond to ESI alone. In terms of owner 342 
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perceived outcome, ESI was subjectively not as effective as surgical decompression in 343 
regard to improving owner assessed mobility, quality of life but particularly pain (Fig. 344 
3). There was a trend towards reduced pain, increased mobility, and greater quality of 345 
life score between sequential modalities, which appeared subjectively more marked in 346 
the pain score, where a difference of over three score points was observed between both 347 
mean and median initial and post-surgical score points. This data seems to indicate that 348 
decompressive surgery might be a superior treatment to single ESI in DLSS cases. 349 
The role of ESI as an accurate predictor of clinical or owner perceived outcome 350 
following decompressive surgery is less clear. All dogs enrolled in and completing this 351 
study, which underwent surgical decompression, showed a positive response. This was 352 
the case despite some having previously failed to respond to a single-instillation ESI. 353 
Also, some dogs responded so well to a single ESI that subsequent surgical 354 
decompression was not performed. Therefore, our initial hypothesis that a positive ESI 355 
response could indicate a successful outcome of subsequent decompression, could not 356 
be confirmed. 357 
Needle placement confirmation for epidural injection relies on techniques such 358 
as the hanging-drop, loss-of-resistance test, pressure-waves measurement, 359 
epidurography, fluoroscopy, ultrasonography and epidural electrical stimulation 360 
(Valverde, 2008; Adami and Gendron, 2017). The epidural electrical stimulation 361 
method utilised in this study has been reported to possess a specificity of 93% and a 362 
sensitivity of 74% in the lumbosacral joint (Garcia-Pereira et al., 2010). Despite all 363 
epidural injections being performed by experienced clinicians, it is possible that the 364 
dogs that failed to respond to ESI may have been injected outside of the epidural space. 365 
However, no systemic side-effects (e.g. polyuria or polydipsia) were reported by the 366 
owners of those dogs. 367 
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All dogs presenting with concurrent pathologies including pelvic limb 368 
orthopaedic disease were excluded from this study. Despite not being within the scope 369 
of this study, the 84.4% short term response rate to ESI suggests that ESI may be a 370 
useful diagnostic procedure to help establish the contribution of DLSS to pelvic limb 371 
dysfunction from concurrent pathologies in dogs (e.g. acute or chronic orthopaedic 372 
disease affecting the hips or stifles). 373 
A series of limitations exist in this study. Clinical outcome information relied on 374 
the expertise of the same people that performed the procedures, potentiating clinician 375 
bias. Owner perceived outcome is inherently subjective, prone to caregiver placebo 376 
effect that may be impacted by the relative cost of ESI versus surgical decompression. 377 
The utilisation of a subjective numeric grading for owner perceived outcome was not 378 
based on a previously validated method. 379 
 380 
Conclusion 381 
This study confirms the previously reported efficacy of ESI as a treatment of 382 
DLSS although a positive response was not achieved in all cases. The mechanisms 383 
behind this response remain unexplained. Epidural steroid injection appears inferior to 384 
surgical decompression according to clinical and owner perceived outcome. Although 385 
surgical decompression appears the preferable option to control long-term clinical signs 386 
relating to DLSS, ESI resulted in a complete and apparently long-term sustained 387 
resolution of clinical signs in a subset of dogs. This suggests that ESI may play a role in 388 
the management of DLSS cases when surgery is not an option, or indeed as an initial 389 
treatment at time of diagnosis. Response to ESI was not able to predict the short-term 390 
surgical outcome in this subset of dogs.  Further studies are needed to develop a 391 
protocol to identify veterinary patients which might respond long term to ESI alone. 392 
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Tables 514 
Table 1. 515 
Detailed clinical outcome. 516 
 517 
  Initial grading Clinical response to 
epidural steroid 
injection 
  
Relapse 
Surgery 
performed 
Clinical response to surgical 
decompression 
    Severity  Numerical  Yes/No 
Time to relapse 
(months) 
Follow-up time 
(months) 
Case 
1 
Moderate 12 Partial Yes 3 NA BF+DL Partial 
Case 
2 
Mild 13 Partial Yes 0.5 NA BF+DL Complete 
Case 
3 
Mild 17 Complete Yes 3 NA 
No: owner 
refused 
NA 
Case 
4 
Mild 17 Partial Yes 1 NA BF+DL Partial 
Case 
5 
Moderate 10 Partial Yes 3 NA BF Complete 
Case 
6 
Moderate 10 Complete Yes 3 NA 
No: owner 
refused 
NA 
Case 
7 
Mild 18 Complete Yes 3 NA BF+DL Complete 
Case 
8 
Mild 15 Complete No NA 21 
No: persistent 
improvement 
NA 
Case 
9 
Moderate 11 Failed Yes 0.75 NA BF+DL Partial 
Case 
10 
Mild 17 Partial Yes 6 NA No: repeat ESI NA 
Case 
11 
Moderate 13 Failed Yes 2 NA BF+DL Complete 
Case 
12 
Mild 16 Partial Yes 2 NA BF+DL Complete 
Case 
13 
Moderate 13 Complete Yes 0.75 NA BF+DL Partial 
Case 
14 
Moderate 11 Complete Yes 2 NA BF+DL Complete 
Case 
15 
Mild 15 Failed Yes 0.75 NA BF+DL Complete 
Case 
16 
Moderate 12 Partial Yes 0.5 NA 
No: owner 
refused 
NA 
Case 
17 
Mild 15 Complete No NA 13 
No: persistent 
improvement 
NA 
Case 
18 
Moderate 15 Failed Yes 2 NA BF+DL Complete 
Case 
19 
Moderate 15 Partial Yes 2 NA BF+DL Complete 
Case 
20 
Moderate 14 Partial Yes 0.75 NA BF Partial 
Case 
21 
Moderate 14 Partial Yes 5 NA BF Partial 
Case 
22 
Mild 16 Partial Lost  NA NA Lost NA 
Case 
23 
Severe 7 Partial Lost  NA NA Lost NA 
Case 
24 
Severe 12 Complete Yes 2 NA 
No: owner 
refused 
NA 
Case 
25 
Moderate 15 Partial Yes 2 NA BF  Partial 
Case 
26 
Severe 13 Complete No NA 3 
No: persistent 
improvement 
NA 
Case 
27 
Mild 16 Failed Yes 0.5 NA BF+DL Partial 
Case 
28 
Moderate 15 Complete No NA 2 
No: persistent 
improvement 
NA 
Case 
29 
Mild 14 Complete No NA 8 
No: persistent 
improvement 
NA 
Case 
30 
Mild 17 Partial Lost  NA NA Lost NA 
 21 
Case 
31 
Moderate 12 Partial Lost  NA NA Lost NA 
Case 
32 
Mild 17 Partial Lost  NA NA Lost NA 
BF, Bilateral foraminotomy; DL, Dorsal laminectomy; ESI, Epidural steroid injection; 518 
Lost, Lost to follow-up after recheck following epidural steroid injection; NA, Non 519 
applicable. 520 
  521 
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Table 2 522 
Detailed owner perceived outcome for dogs having both ESI and decompressive 523 
surgery. 524 
 
General population (n = 32) Surgically managed (n = 17) 
Initial grade mean 
(median, 
minimum-
maximum) 
Post-epidural 
mean (median, 
minimum-
maximum) 
Initial grade mean 
(median, 
minimum-
maximum) 
Post-epidural 
mean (median, 
minimum-
maximum) 
Post-surgical 
mean (median, 
minimum-
maximum) 
Pain 
(0 no pain – 
10 extreme 
pain) 
5.4 (5; 2-10) 2.9 (3; 0-6) 
5 (5; 2-8) 3.4 (4; 0-6) 1.3 (0; 0-5) 
Mobility 
(0 poor – 10 
good) 
6.2 (6; 2-10) 7.8 (8; 3-10) 
6.5 (7; 3-10) 7.5 (8; 5-10) 9.1 (9; 7-10) 
Quality of 
life 
(0 poor – 10 
good) 
6.2 (6; 0-10) 7.8 (8.5; 2-10) 
6.5 (6; 3-9) 7.2 (8; 2-10) 8.6 (9; 0-10) 
 525 
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Figure legends 527 
Fig. 1. Diagram depicting the clinical trial sequence, included dogs and reasons for 528 
exclusion. 529 
Fig. 2. Box and whiskers plots representing owner perceived pain, mobility and quality 530 
of life scores of the whole population (n = 32) at two time points, initial and following 531 
epidural steroid injection (ESI). Circles beyond the whiskers indicate outliers, with 532 
asterisks identifying extreme outliers. 533 
Fig. 3. Box and whiskers plots representing owner perceived pain, mobility and quality 534 
of life scores of the dogs receiving surgery (n = 17) at three time points, initial, 535 
following epidural steroid injection (ESI), and following surgery decompression. 536 
Circles beyond the whiskers indicate outliers, with asterisks identifying extreme 537 
outliers. 538 
